Opioid Rotation in Renal Failure with Neurotoxicity
Mrs. R is a 64-year-old woman with metastatic pancreatic adenocarcinoma and a 6-month history of midepigastric pain radiating to the back. For the past 3 weeks she has taken morphine extended-release 60 mg PO every 12 hours plus immediate-release morphine 15 mg every 4 hours as needed; she reports using about six rescue doses daily. Her pain is now 8/10 and described as burning and lancinating. Over the past 48 hours she has developed diffuse myoclonus, allodynia over the abdomen, visual hallucinations, and fluctuating somnolence. Labs: creatinine 2.4 mg/dL (baseline 0.9), eGFR 24 mL/min/1.73 m², corrected calcium 9.1 mg/dL, sodium 133 mmol/L. She is not confused but is frightened by the hallucinations. Family asks whether the morphine is 'too much.' She has a peripheral IV and a working transdermal patch site.
1. What is the most likely explanation for the myoclonus, allodynia, and hallucinations, and what immediate actions are indicated?
Read the worked answer
The syndrome is opioid-induced neurotoxicity from accumulation of morphine's renally cleared metabolites (morphine-6-glucuronide and morphine-3-glucuronide), not simply 'too much' analgesia. The timeline - rising creatinine, escalating dose, myoclonus, allodynia/hyperalgesia, hallucinations, and fluctuating sedation - is classic. Hypercalcemia and infection can mimic this, but calcium is normal; check for urinary retention and constipation. Immediate actions: stop the morphine; do not give naloxone unless there is respiratory depression, because it would precipitate severe pain and withdrawal; hydrate if appropriate; rotate to a renally safer opioid, preferably fentanyl (or cautiously methadone with ECG if QTc is normal); add clonazepam 0.5 mg PO/SC q8h prn for myoclonus; treat constipation; counsel family that this is accumulation, not an overdose or addiction. Monitor sedation, respiratory rate, and pain every few hours.
2. Calculate a reasonable starting dose if you rotate to transdermal fentanyl, and state the key safety steps.
Read the worked answer
Total daily oral morphine is 60 mg × 2 = 120 mg ER plus about six 15-mg rescue doses = 90 mg, for roughly 210 mg/day. Using a conservative standard conversion, 60 mg/day of oral morphine is approximately 25 mcg/h fentanyl; 210 mg/day falls in the 150–210 mg band, corresponding to about 75–100 mcg/h. Because cross-tolerance is incomplete after a toxic rotation, reduce by 25–50%, starting at 50–75 mcg/h. Given her renal failure and recent neurotoxicity, I would start at the lower end (50 mcg/h) and provide fentanyl 25–50 mcg IV/SC q1h prn or hydromorphone cautiously for breakthrough, with reassessment in 12–24 hours. Do not rely on the patch alone for uncontrolled pain; patches take 12–24 hours to reach effect. Confirm the old opioid is stopped, prescribe a bowel regimen and adjuvant, and monitor for recurrent toxicity. Avoid transdermal patches in febrile or diaphoretic patients if absorption is unreliable.
3. What non-opioid adjuvants and monitoring would you add?
Read the worked answer
Add gabapentin or pregabalin for neuropathic pain, adjusting for renal function (for example, gabapentin 100–300 mg at night), and consider duloxetine if there is no contraindication. Continue dexamethasone only if it addresses tumor edema or pain and monitor glucose. For myoclonus, use clonazepam; for hallucinations, treat the underlying opioid toxicity rather than adding an antipsychotic, though low-dose haloperidol can be used if distressing. Nonpharmacologic measures include heat, positioning, and distraction. Monitor pain score, sedation scale, respiratory rate, myoclonus, bowel function, and hydration. If pain remains uncontrolled despite rotation, reassess the pain mechanism and consider a nerve block or palliative radiation for the pancreatic mass. Document the equianalgesic rationale and educate the family that rotation is a standard safety step, not a sign of 'running out of options.'